You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood small noncleaved cell lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

      Suspended
      • Recurrent Aggressive Non-Hodgkin Lymphoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 12, 2023

      Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,

      Completed
      • Grade 3a Follicular Lymphoma
      • +9 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 31, 2023

      Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

      Active, not recruiting
      • Aggressive Non-Hodgkin Lymphoma
      • +9 more
      • Cryosurgery
      • +5 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 9, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Duarte, California
      • +2 more
      Oct 7, 2022

      AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

      Completed
      Has Results
      • AIDS-related Diffuse Large Cell Lymphoma
      • +8 more
      • Eldoret, Kenya
      • +1 more
      Sep 12, 2022

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      Has Results
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +20 more
      • Scottsdale, Arizona
      • +1 more
      May 6, 2022

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 17, 2022

      Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +20 more
      • Chimeric Antigen Receptor T-Cell Therapy
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 11, 2022

      Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

      Completed
      Has Results
      • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
      • Recurrent Childhood B-Lymphoblastic Lymphoma
      • San Diego, California
      • +2 more
      Sep 13, 2022

      Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

      Terminated
      Has Results
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +12 more
      • Laboratory Biomarker Analysis
      • ROR1 CAR-specific Autologous T-Lymphocytes
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 11, 2022

      Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

      Completed
      • Acute Undifferentiated Leukemia
      • +63 more
      • total-body irradiation
      • +7 more
      • Seattle, Washington
      • +1 more
      Jan 17, 2020

      Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

      Recruiting
      • Melanoma
      • +14 more
      • LITT + Pembrolizumab
      • Gainesville, Florida
      • +1 more
      Aug 22, 2022

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +7 more
      • Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jul 14, 2022

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

      Recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +13 more
      • Polatuzumab Vedotin
      • +3 more
      • Scottsdale, Arizona
      • +11 more
      Aug 23, 2022

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Completed
      Has Results
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +99 more
      • alemtuzumab
      • +6 more
      • Denver, Colorado
      • +6 more
      Jan 15, 2020

      Patients Previously Treated WithMustang Bio CAR-T Cell

      Enrolling by invitation
      • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
      • +10 more
      • Prior MB-102 CAR-T cell investigational product.
      • Prior MB-106 CAR-T cell investigational product.
      • Duarte, California
      • +4 more
      Dec 8, 2022

      Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

      Completed
      • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
      • +76 more
      • fludarabine phosphate
      • +6 more
      • Tucson, Arizona
      • +10 more
      Jan 17, 2020

      Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

      Recruiting
      • Follicular B-cell Non-Hodgkin's Lymphoma
      • +7 more
      • MB-106
      • Orange, California
      • +3 more
      Nov 1, 2022

      Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

      Completed
      • Chronic Myeloproliferative Disorders
      • +5 more
      • sargramostim
      • Buffalo, New York
        Roswell Park Cancer Institute
      Oct 3, 2022